FOLD (STOCKS)
Amicus Therapeutics, Inc
$14.330000
+0.030000 (+0.21%)
Prev close: $14.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Bradley Lewis Campbell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,495.38M
- Employees
- 499
- P/E (TTM)
- -319.91
- P/B (TTM)
- 19.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
8
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.06 | $0.04 | +0.0207 | +52.67% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.12 | +0.0501 | +41.72% |
|
Mar 2025 (Q1)
|
$-0.07 | $-0.06 | -0.0145 | -26.13% |
|
Dec 2024 (Q4)
|
$0.05 | $0.01 | +0.0353 | +240.14% |
Financial Statements
| Assets | $868.81M |
| Current Assets | $594.07M |
| Inventory | $177.93M |
| Other Current Assets | $416.14M |
| Noncurrent Assets | $274.75M |
| Fixed Assets | $27.76M |
| Intangible Assets | $14.74M |
| Other Non-current Assets | $232.24M |
| Liabilities | $638.39M |
| Current Liabilities | $198.93M |
| Accounts Payable | $19.10M |
| Other Current Liabilities | $179.83M |
| Noncurrent Liabilities | $439.46M |
| Long-term Debt | $391.99M |
| Other Non-current Liabilities | $47.47M |
| Equity | $230.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $230.42M |
| Liabilities And Equity | $868.81M |